Popular Articles

SVS 2009: Ziehm Imaging Sets A New Standard In Mobile Imaging With The Ziehm Vision RFD
Ziehm Imaging is proud to announce that the United States Food and Drug Administration (FDA) has given 510k clearance for the latest innovative mobile C-arm from Ziehm Imaging, the Ziehm Vision(R) RFD, for marketing and sales within the United States. Designed for use in endovascular surgery, interventional cardiology and interventional radiology, the Ziehm Vision RFD mobile C-arm combines the latest flat-panel technology and a true fully digital imaging chain with a compact design that delivers exceptional image quality. During demanding procedures physicians will benefit from improved visualization, workflow and reduced radiation dose.

Howard County Pharmacy Owner Indicted For Health Care Fraud
A federal grand jury yesterday indicted Pamela Arrey, age 48, of
News of the day
Review: Long-term Use Of Lymphoma Drug Extends Lives
A new Cochrane Library review confirms that years-long use of a drug called rituximab extends the lifespan of people with one of the milder forms of lymphoma.
Nutrition

Mapping Gene Expression With Gene Expression Atlas

Recently, researchers at the European Molecular Biology Laboratory"s European Bioinformatics Institute (EMBL-EBI) launched a new database, the Gene Expression Atlas, which allows scientists to search and compare gene expression data at unprecedented detail and scope. Observing how gene expression varies in different cell types, tissues and under disease conditions can help researchers understand gene function and to develop new drugs and therapies. Although most cells in an organism share the same genetic information, different cell types, for example skin and liver cells, have different properties and functions, largely because different genes are active in these cells. The Gene Expression Atlas is a new database that allows users to query gene expression under a range of biological conditions, including different cell types, developmental stages, physiological states, phenotypes and disease states. The key questions this new database can answer can be summarised as: 1. under which conditions is my particular gene of interest expressed? 2. which genes are expressed in a particular condition? For example, what genes are specifically active in kidney cells, or how does the expression of genes in leukemic blood differ compared to normal blood? Both questions can also be combined to focus on particular genes and their role in a specific disease, such as identifying members of the Wnt signalling pathway that are expressed in cancer. The Atlas collates data from over 1000 different independent studies, mainly microarray experiments, with more than 30,000 samples in total. The new database is the latest product of the EBI"s Microarray Informatics group and has its origins in the EBI"s ArrayExpress re. After a phase of development, the Atlas is ready to begin its own life as an independent major re. Misha Kapushesky, Atlas project leader at the EBI commented, "While the ArrayExpress Archive makes data from high throughput functional genomics assays available to experts, Gene Expression Atlas presents this information in a format accessible to any biologist. The Atlas takes data directly from the ArrayExpress Archive, which is then enriched by curation, re-annotation and statistical computations before the results are presented to the user in an easily accessible form." Notes: The Gene Expression Atlas has already found use in the pharmaceuticals industry as a valuable research platform. The re can be accessed from http://www.ebi.ac.uk/gxa and the Microarray Informatics group have produced an e-learning tutorial to guide users on how to get the most from the Atlas. This tutorial is freely available from the EBI"s e-learning portal at http://www.ebi.ac.uk/training/elearningcentral/. Gene Expression atlas: http://www.ebi.ac.uk/gxa For more information please check: http://www.ebi.ac.uk Katrina Pavelin European Molecular Biology Laboratory


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):